Anlon Healthcare profit and loss

Latest FY26

Revenue: ₹172cr
EBITDA: ₹47.5cr
Net profit: ₹29.1cr
EPS: ₹6.11

₹ crore except per share

Tap a line for its trend	FY26Mar 2026

Expenses
	172
	0.3
	172
	149
	−44.2
	5.5
	3.7
	1.5
	13.8
	130
	47.5
	46.0
Profit
	42.5
	42.5
	11.8
	1.6
	13.4
	29.1
	29.1
	−0.1
	29.0
	28.5
	0.6
Per share
	₹6.11
	₹6.11
Other comprehensive income — detail
	−0.1
	0.1
	−0.0
	28.5
	0.6
Per share — as-filed variants
	₹6.11
	₹6.11
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	66.9
	38.9%
Adjusted (ex-exceptional items) — derived
	42.5
	29.1
	₹6.11

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

AHCL₹24.47

Anlon Healthcare Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersANUHPHR WANBURY BAJAJHCARE ZIMLAB THEMISMED LINCOLN SIGACHI VALIANTLABMcap ₹130 Cr

View

	In ₹ Crore except Per Share 12 Months Ending	FY26 31/03/2026
	Revenue from Operations	172.0
	Other Income	0.3
	Total Income	172.2
	Expenses
	+ Cost of Materials Consumed	149.3
	+ Changes in Inventories	-44.2
	+ Employee Benefit Expense	5.5
	+ Finance Costs	3.7
	+ Depreciation & Amortisation	1.5
	+ Other Expenses	13.8
	Total Expenses	129.7
	EBITDA	47.5
	EBIT	46.0
	Profit
	PBT before Exceptional Items	42.5
	Pretax Income	42.5
	+ Current Tax	11.8
	+ Deferred Tax	1.6
	Tax Expense	13.4
	Net Income	29.1
	+ Net Income — Continuing Ops	29.1
	+ Other Comprehensive Income	-0.1
	Total Comprehensive Income	29.0
	Net Income to Common	28.5
	Minority Interest	0.6
	Per Share
	Basic EPS	6.11
	Diluted EPS	6.11
	Other Comprehensive Income — detail
	+ Other Comprehensive Income	-0.1
	+ Tax on Items NOT to be Reclassified	0.1
	+ Tax on Items to be Reclassified	-0.0
	Comprehensive Income — Owners of Parent	28.5
	Comprehensive Income — Non-controlling Interests	0.6
	Per Share — as-filed variants
	Basic EPS — Continuing Operations	6.11
	Diluted EPS — Continuing Operations	6.11
	Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
	Gross Profit	66.9
	Gross Margin %	38.88
	Adjusted (ex-Exceptional Items) — derived
	Pretax Income (Adjusted, as filed)	42.5
	Net Income Adj (tax-effected)	29.1
	EPS Adj	6.11
	Other Filed Concepts — mapped but not yet placed in the schedule
	Face Value	10.00
	Paid Up Equity Capital	53.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.